Name
osaühing KASTANI APTEEK
Registry code
10164346
VAT number
EE100661077
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
02.12.1996 (27)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
47731 - Dispensing chemist in specialised stores
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Evelin Sarap 20.05.1967 (57) | 100% - 2 556.00 EUR | Board member (chairman) | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| EVERO INVEST OÜ 11170113 | 50% - 1 278.00 EUR | - | - |
| 2019 03.08.2020 | 2020 28.06.2021 | 2021 08.07.2022 | 2022 16.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 792 472 € | 810 166 € | 818 968 € | 987 486 € |
| Net profit (loss) for the period | 44 867 € | 20 700 € | 60 293 € | 71 555 € |
| Profit Margin | 6% | 3% | 7% | 7% |
| Current Assets | 389 869 € | 377 093 € | 455 401 € | 551 147 € |
| Fixed Assets | 59 603 € | 58 439 € | 57 275 € | 56 747 € |
| Total Assets | 449 472 € | 435 532 € | 512 676 € | 607 894 € |
| Current Liabilities | 132 659 € | 98 019 € | 114 870 € | 138 533 € |
| Non Current Liabilities | 0 € | 0 € | 0 € | 0 € |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 316 813 € | 337 513 € | 397 806 € | 469 361 € |
| Employees | 3 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 227 277.33 € | 15 285.81 € | 11 402.35 € | 3 |
| 2023 Q4 | 241 348.98 € | 14 834.19 € | 10 365.36 € | 3 |
| 2023 Q3 | 214 001.1 € | 13 962.71 € | 10 096.13 € | 3 |
| 2023 Q2 | 233 750.27 € | 19 807.53 € | 15 016.76 € | 3 |
| 2023 Q1 | 251 402.64 € | 21 023.38 € | 15 135.31 € | 3 |
| 2022 Q4 | 265 489.59 € | 15 914.3 € | 10 543.86 € | 4 |
| 2022 Q3 | 204 859.47 € | 11 673.6 € | 9 506.35 € | 3 |
| 2022 Q2 | 243 441.63 € | 14 090.22 € | 8 570.84 € | 3 |
| 2022 Q1 | 253 515.32 € | 16 258.52 € | 10 621.85 € | 3 |
| 2021 Q4 | 251 844.26 € | 13 129.46 € | 7 265.74 € | 3 |
| 2021 Q3 | 170 584.54 € | 9 395.16 € | 5 998.86 € | 3 |
| 2021 Q2 | 192 544.76 € | 11 123.05 € | 8 214.18 € | 3 |
| 2021 Q1 | 192 260.89 € | 11 156.98 € | 8 313.66 € | 3 |
| 2020 Q4 | 181 789.39 € | 10 661.56 € | 7 575.54 € | 3 |
| 2020 Q3 | 155 952.89 € | 7 261.2 € | 7 650.66 € | 3 |
| 2020 Q2 | 270 896.97 € | 18 275.21 € | 10 516.96 € | 3 |
| 2020 Q1 | 212 479.14 € | 12 228.62 € | 8 878.4 € | 3 |
